Tapewire

Nasdaq · USD

CPIX

CUMBERLAND PHARMACEUTICALS INC

Export transactions ↓
Tapewire entity
6757
SEC CIK
0001087294
Parsed reports
362

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 19, 2021 Filed Jul 9, 2021 21:10 UTC
Cearnal Martin EDirector · Sr VP/Chief Commercial Officer
PurchaseCommon Stock 105 $2.83 $297.15
Disclosure

SEC source: 0001209191-21-046210 · doc4.xml · nonDerivative · entry 2

Cearnal Martin E · CIK 0001408500 · Director · Sr VP/Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 162,009

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 19, 2021 Filed Sep 10, 2021 21:19 UTC
KAZIMI A JDirector · Chairman and CEO · 10% owner
PurchaseCommon Stock 15 $2.83 $42.45
Disclosure

SEC source: 0001209191-21-055496 · doc4.xml · nonDerivative · entry 24

KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,768,079

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 19, 2021 Filed Sep 10, 2021 21:12 UTC PurchaseCommon Stock 15 $2.83 $42.45
Disclosure

SEC source: 0001209191-21-055488 · doc4.xml · nonDerivative · entry 24

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,293

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 18, 2021 Filed Jun 11, 2021 21:16 UTC GrantCommon Stock 85 $2.89 $245.65
Disclosure

SEC source: 0001209191-21-039931 · doc4.xml · nonDerivative · entry 24

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 169,450

F2 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 18, 2021 Filed Jul 9, 2021 21:10 UTC
Cearnal Martin EDirector · Sr VP/Chief Commercial Officer
PurchaseCommon Stock 105 $2.91 $305.55
Disclosure

SEC source: 0001209191-21-046210 · doc4.xml · nonDerivative · entry 1

Cearnal Martin E · CIK 0001408500 · Director · Sr VP/Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 161,904

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 18, 2021 Filed Sep 10, 2021 21:19 UTC
KAZIMI A JDirector · Chairman and CEO · 10% owner
PurchaseCommon Stock 15 $2.89 $43.35
Disclosure

SEC source: 0001209191-21-055496 · doc4.xml · nonDerivative · entry 23

KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,768,064

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 18, 2021 Filed Sep 10, 2021 21:12 UTC PurchaseCommon Stock 15 $2.89 $43.35
Disclosure

SEC source: 0001209191-21-055488 · doc4.xml · nonDerivative · entry 23

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,278

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 17, 2021 Filed Jun 8, 2021 21:22 UTC
Cearnal Martin EDirector · Sr VP/Chief Commercial Officer
PurchaseCommon Stock 5,700 $2.83 $16,131.00
Disclosure

SEC source: 0001209191-21-038980 · doc4.xml · nonDerivative · entry 25

Cearnal Martin E · CIK 0001408500 · Director · Sr VP/Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 161,799

F4 · shares: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.805 to $2.8797, inclusive.

Read SEC document
May 17, 2021 Filed Jun 8, 2021 21:22 UTC
Cearnal Martin EDirector · Sr VP/Chief Commercial Officer
PurchaseCommon Stock 105 $2.84 $298.20
Disclosure

SEC source: 0001209191-21-038980 · doc4.xml · nonDerivative · entry 24

Cearnal Martin E · CIK 0001408500 · Director · Sr VP/Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,099

F2 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 17, 2021 Filed Jun 11, 2021 21:16 UTC GrantCommon Stock 85 $2.84 $241.40
Disclosure

SEC source: 0001209191-21-039931 · doc4.xml · nonDerivative · entry 23

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 169,365

F2 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 17, 2021 Filed Jun 11, 2021 21:07 UTC
Bonner MichaelChief Financial Officer
Disposition to issuerOptions (right to buy) · Derivative 5,000 $0.00 Strike: $3.22 $0.00
Disclosure

SEC source: 0001209191-21-039917 · doc4.xml · derivative · entry 4

Bonner Michael · CIK 0001666790 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2031-03-17

F2 · shares: Resigned position as Chief Financial Officer effective May 17, 2021. All unvested equity awards forfeited upon resignation.

Read SEC document
May 17, 2021 Filed Jun 11, 2021 21:07 UTC
Bonner MichaelChief Financial Officer
OtherCommon Stock 7,500 $2.83 $21,225.00
Disclosure

SEC source: 0001209191-21-039917 · doc4.xml · nonDerivative · entry 2

Bonner Michael · CIK 0001666790 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,720

F2 · shares: Resigned position as Chief Financial Officer effective May 17, 2021. All unvested equity awards forfeited upon resignation.

Read SEC document
May 17, 2021 Filed Sep 10, 2021 21:19 UTC
KAZIMI A JDirector · Chairman and CEO · 10% owner
PurchaseCommon Stock 15 $2.84 $42.60
Disclosure

SEC source: 0001209191-21-055496 · doc4.xml · nonDerivative · entry 22

KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,768,049

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 17, 2021 Filed Sep 10, 2021 21:12 UTC PurchaseCommon Stock 15 $2.84 $42.60
Disclosure

SEC source: 0001209191-21-055488 · doc4.xml · nonDerivative · entry 22

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,263

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 14, 2021 Filed Jun 8, 2021 21:22 UTC
Cearnal Martin EDirector · Sr VP/Chief Commercial Officer
PurchaseCommon Stock 5,000 $2.77 $13,850.00
Disclosure

SEC source: 0001209191-21-038980 · doc4.xml · nonDerivative · entry 23

Cearnal Martin E · CIK 0001408500 · Director · Sr VP/Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 155,994

F3 · shares: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.715 to $2.792, inclusive. The reporting person undertakes to provide to Cumberland Pharmaceuticals Inc., any security holder of Cumberland Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (3) and (4) to this Form 4.

Read SEC document
May 14, 2021 Filed Jun 8, 2021 21:22 UTC
Cearnal Martin EDirector · Sr VP/Chief Commercial Officer
PurchaseCommon Stock 105 $2.81 $295.05
Disclosure

SEC source: 0001209191-21-038980 · doc4.xml · nonDerivative · entry 22

Cearnal Martin E · CIK 0001408500 · Director · Sr VP/Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,994

F2 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 14, 2021 Filed Jun 11, 2021 21:16 UTC GrantCommon Stock 85 $2.81 $238.85
Disclosure

SEC source: 0001209191-21-039931 · doc4.xml · nonDerivative · entry 22

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 169,280

F2 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 14, 2021 Filed Sep 10, 2021 21:19 UTC
KAZIMI A JDirector · Chairman and CEO · 10% owner
PurchaseCommon Stock 15 $2.81 $42.15
Disclosure

SEC source: 0001209191-21-055496 · doc4.xml · nonDerivative · entry 21

KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,768,034

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 14, 2021 Filed Sep 10, 2021 21:12 UTC PurchaseCommon Stock 15 $2.81 $42.15
Disclosure

SEC source: 0001209191-21-055488 · doc4.xml · nonDerivative · entry 21

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,248

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 13, 2021 Filed Jun 8, 2021 21:22 UTC
Cearnal Martin EDirector · Sr VP/Chief Commercial Officer
PurchaseCommon Stock 105 $2.88 $302.40
Disclosure

SEC source: 0001209191-21-038980 · doc4.xml · nonDerivative · entry 21

Cearnal Martin E · CIK 0001408500 · Director · Sr VP/Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,889

F2 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 13, 2021 Filed Jun 11, 2021 21:16 UTC GrantCommon Stock 85 $2.88 $244.80
Disclosure

SEC source: 0001209191-21-039931 · doc4.xml · nonDerivative · entry 21

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 169,195

F2 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 13, 2021 Filed Sep 10, 2021 21:19 UTC
KAZIMI A JDirector · Chairman and CEO · 10% owner
PurchaseCommon Stock 15 $2.88 $43.20
Disclosure

SEC source: 0001209191-21-055496 · doc4.xml · nonDerivative · entry 20

KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,768,019

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 13, 2021 Filed Sep 10, 2021 21:12 UTC PurchaseCommon Stock 15 $2.88 $43.20
Disclosure

SEC source: 0001209191-21-055488 · doc4.xml · nonDerivative · entry 20

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,233

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 12, 2021 Filed Jun 8, 2021 21:22 UTC
Cearnal Martin EDirector · Sr VP/Chief Commercial Officer
PurchaseCommon Stock 105 $2.86 $300.30
Disclosure

SEC source: 0001209191-21-038980 · doc4.xml · nonDerivative · entry 20

Cearnal Martin E · CIK 0001408500 · Director · Sr VP/Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,784

F2 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 12, 2021 Filed Jun 11, 2021 21:16 UTC GrantCommon Stock 85 $2.86 $243.10
Disclosure

SEC source: 0001209191-21-039931 · doc4.xml · nonDerivative · entry 20

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 169,110

F2 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 12, 2021 Filed Sep 10, 2021 21:19 UTC
KAZIMI A JDirector · Chairman and CEO · 10% owner
PurchaseCommon Stock 15 $2.86 $42.90
Disclosure

SEC source: 0001209191-21-055496 · doc4.xml · nonDerivative · entry 19

KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,768,004

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 12, 2021 Filed Sep 10, 2021 21:12 UTC PurchaseCommon Stock 15 $2.86 $42.90
Disclosure

SEC source: 0001209191-21-055488 · doc4.xml · nonDerivative · entry 19

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,218

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 11, 2021 Filed Jun 8, 2021 21:22 UTC
Cearnal Martin EDirector · Sr VP/Chief Commercial Officer
PurchaseCommon Stock 105 $2.68 $281.40
Disclosure

SEC source: 0001209191-21-038980 · doc4.xml · nonDerivative · entry 19

Cearnal Martin E · CIK 0001408500 · Director · Sr VP/Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,679

F2 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 11, 2021 Filed Jun 11, 2021 21:16 UTC GrantCommon Stock 85 $2.68 $227.80
Disclosure

SEC source: 0001209191-21-039931 · doc4.xml · nonDerivative · entry 19

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 169,025

F2 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 11, 2021 Filed Sep 10, 2021 21:19 UTC
KAZIMI A JDirector · Chairman and CEO · 10% owner
PurchaseCommon Stock 15 $2.68 $40.20
Disclosure

SEC source: 0001209191-21-055496 · doc4.xml · nonDerivative · entry 18

KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,767,989

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 11, 2021 Filed Sep 10, 2021 21:12 UTC PurchaseCommon Stock 15 $2.68 $40.20
Disclosure

SEC source: 0001209191-21-055488 · doc4.xml · nonDerivative · entry 18

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,203

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 10, 2021 Filed Jun 8, 2021 21:22 UTC
Cearnal Martin EDirector · Sr VP/Chief Commercial Officer
PurchaseCommon Stock 105 $2.71 $284.55
Disclosure

SEC source: 0001209191-21-038980 · doc4.xml · nonDerivative · entry 18

Cearnal Martin E · CIK 0001408500 · Director · Sr VP/Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,574

F2 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 10, 2021 Filed Jun 11, 2021 21:16 UTC GrantCommon Stock 85 $2.71 $230.35
Disclosure

SEC source: 0001209191-21-039931 · doc4.xml · nonDerivative · entry 18

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 168,940

F2 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 10, 2021 Filed Sep 10, 2021 21:19 UTC
KAZIMI A JDirector · Chairman and CEO · 10% owner
PurchaseCommon Stock 15 $2.71 $40.65
Disclosure

SEC source: 0001209191-21-055496 · doc4.xml · nonDerivative · entry 17

KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,767,974

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 10, 2021 Filed Sep 10, 2021 21:12 UTC PurchaseCommon Stock 15 $2.71 $40.65
Disclosure

SEC source: 0001209191-21-055488 · doc4.xml · nonDerivative · entry 17

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,188

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 07, 2021 Filed Jun 8, 2021 21:22 UTC
Cearnal Martin EDirector · Sr VP/Chief Commercial Officer
PurchaseCommon Stock 105 $2.73 $286.65
Disclosure

SEC source: 0001209191-21-038980 · doc4.xml · nonDerivative · entry 17

Cearnal Martin E · CIK 0001408500 · Director · Sr VP/Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,469

F2 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 07, 2021 Filed Jun 11, 2021 21:16 UTC GrantCommon Stock 85 $2.73 $232.05
Disclosure

SEC source: 0001209191-21-039931 · doc4.xml · nonDerivative · entry 17

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 168,855

F2 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 07, 2021 Filed Sep 10, 2021 21:19 UTC
KAZIMI A JDirector · Chairman and CEO · 10% owner
PurchaseCommon Stock 15 $2.73 $40.95
Disclosure

SEC source: 0001209191-21-055496 · doc4.xml · nonDerivative · entry 16

KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,767,959

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 07, 2021 Filed Sep 10, 2021 21:12 UTC PurchaseCommon Stock 15 $2.73 $40.95
Disclosure

SEC source: 0001209191-21-055488 · doc4.xml · nonDerivative · entry 16

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,173

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 06, 2021 Filed Jun 8, 2021 21:22 UTC
Cearnal Martin EDirector · Sr VP/Chief Commercial Officer
PurchaseCommon Stock 105 $2.74 $287.70
Disclosure

SEC source: 0001209191-21-038980 · doc4.xml · nonDerivative · entry 16

Cearnal Martin E · CIK 0001408500 · Director · Sr VP/Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,364

F2 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 06, 2021 Filed Jun 11, 2021 21:16 UTC GrantCommon Stock 85 $2.74 $232.90
Disclosure

SEC source: 0001209191-21-039931 · doc4.xml · nonDerivative · entry 16

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 168,770

F2 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 06, 2021 Filed Sep 10, 2021 21:19 UTC
KAZIMI A JDirector · Chairman and CEO · 10% owner
PurchaseCommon Stock 15 $2.74 $41.10
Disclosure

SEC source: 0001209191-21-055496 · doc4.xml · nonDerivative · entry 15

KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,767,944

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 06, 2021 Filed Sep 10, 2021 21:12 UTC PurchaseCommon Stock 15 $2.74 $41.10
Disclosure

SEC source: 0001209191-21-055488 · doc4.xml · nonDerivative · entry 15

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,158

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 05, 2021 Filed Jun 8, 2021 21:22 UTC
Cearnal Martin EDirector · Sr VP/Chief Commercial Officer
PurchaseCommon Stock 105 $2.73 $286.65
Disclosure

SEC source: 0001209191-21-038980 · doc4.xml · nonDerivative · entry 15

Cearnal Martin E · CIK 0001408500 · Director · Sr VP/Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,259

F2 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 05, 2021 Filed Jun 11, 2021 21:16 UTC GrantCommon Stock 85 $2.73 $232.05
Disclosure

SEC source: 0001209191-21-039931 · doc4.xml · nonDerivative · entry 15

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 168,685

F2 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 05, 2021 Filed Sep 10, 2021 21:19 UTC
KAZIMI A JDirector · Chairman and CEO · 10% owner
PurchaseCommon Stock 15 $2.73 $40.95
Disclosure

SEC source: 0001209191-21-055496 · doc4.xml · nonDerivative · entry 14

KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,767,929

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 05, 2021 Filed Sep 10, 2021 21:12 UTC PurchaseCommon Stock 15 $2.73 $40.95
Disclosure

SEC source: 0001209191-21-055488 · doc4.xml · nonDerivative · entry 14

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,143

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 04, 2021 Filed Jun 8, 2021 21:22 UTC
Cearnal Martin EDirector · Sr VP/Chief Commercial Officer
PurchaseCommon Stock 105 $2.66 $279.30
Disclosure

SEC source: 0001209191-21-038980 · doc4.xml · nonDerivative · entry 14

Cearnal Martin E · CIK 0001408500 · Director · Sr VP/Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,154

F2 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 04, 2021 Filed Jun 11, 2021 21:16 UTC GrantCommon Stock 85 $2.66 $226.10
Disclosure

SEC source: 0001209191-21-039931 · doc4.xml · nonDerivative · entry 14

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 168,600

F2 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document
May 04, 2021 Filed Sep 10, 2021 21:19 UTC
KAZIMI A JDirector · Chairman and CEO · 10% owner
PurchaseCommon Stock 15 $2.66 $39.90
Disclosure

SEC source: 0001209191-21-055496 · doc4.xml · nonDerivative · entry 13

KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,767,914

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.